Analysis of the Global Vaccines Delivery Market

Innovative Technologies and Future Trends for Stakeholders

USD 4,950.00

* Required Fields

USD 4,950.00


Be the first to review this product

The global market for vaccines is estimated to be only 2-3% of the total pharmaceuticals market in 2014; however, this sector has been continuously experiencing a stellar growth rate of 10-15% per year versus the 5-7% seen in the overall market. Currently, the most commonly available vaccines are administered by injection, which makes mass immunization more costly and less safe, particularly in resource-poor developing countries. More than 120 new products are currently in the development pipeline, of which sixty hold significant importance to developing nations. The type of delivery system will predict which type of vaccine delivery will remain the most attractive (in terms of revenue) for stakeholders in the

Table of Contents

Executive SummaryKey FindingsKey Findings (continued)Key Findings—Options in the Global Vaccine Delivery MarketUnmet Needs in the Global Vaccine Delivery MarketScope and SegmentationKey Questions This Study Will AnswerMarket Engineering MeasurementsMarket Engineering Measurements (continued)CEO’s PerspectiveKey Companies to WatchKey Companies to Watch (continued)3 Key PredictionsMarket OverviewMarket BackgroundMarket Segmentation Segmentation by Type of DeliverySegmentation by Region and Top 10 Vaccine Product Sales in 2013Segmentation by Top 5 Competitors Competitive PlaybookNew Market OpportunitiesPipeline of Vaccine Delivery SystemsAttractiveness in Vaccine Delivery MarketDrivers, Restraints, and Trends—Total Vaccine Delivery MarketMarket DriversDrivers ExplainedMarket RestraintsRestraints ExplainedForecasts and Trends—Total Vaccine Delivery MarketMarket Engineering MeasurementsForecast Assumptions and DefinitionsRevenue ForecastRevenue Forecast by SegmentRevenue Forecast DiscussionInjectable Vaccine Delivery Market HighlightsHigh Potential Segment for Injectable Vaccine Delivery—Influenza (Flu)Key Vaccine Companies (Private)Porter’s Five Force AnalysisInjectable Vaccine Delivery MarketMarket Engineering MeasurementsRevenue ForecastRevenue Forecast DiscussionInjectable Vaccine Delivery System Expected to Remain in Demand—Results of Recent SurveyCompetitive AssessmentInjectable Vaccine With Promising Future—Pneumococcal Vaccine (PCV13)Oral Vaccine Delivery MarketMarket Engineering MeasurementsRevenue ForecastRevenue Forecast DiscussionCompetitive AssessmentOther Vaccine Deliveries MarketMarket Engineering MeasurementsRevenue ForecastCompetitive AssessmentOther Vaccine Deliveries with Promising Future—Intranasal Flu SprayNew Technologies and Vaccine Trends by RegionGlobal—Polio Vaccine TrendsIndia—Polio Vaccine TrendsThe United States—New Vaccine TechnologyEurope—New Vaccine TechnologyOther Regions (APAC)—New Vaccine TechnologyKey Companies to WatchBecton Dickinson and Company (BD)BioCSLNovavax Inc.Vaxart Inc.VaxxasKey ConclusionsFuture of Vaccine Delivery SystemsKey ConclusionsFrost & Sullivan AwardsLegal DisclaimerAppendixMarket Engineering MethodologyLearn More—Next Steps


Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.